Home » Authors » Mark Lawson

Articles by Mark Lawson

Amrad Reports Positive AM336 Trial Results, Raises A$15.5M

March 6, 2002

Amrad Reports Positive AM336 Trial Results, Raises A$15.5M

March 6, 2002

Australian Researchers Isolate Gene Implicated In Hay Fever

Feb. 20, 2002

Australian Researchers Isolate Gene Implicated In Hay Fever

Feb. 20, 2002

Metabolic Eyeing Phase IIb Trial In Obesity After Positive IIa Study

Feb. 13, 2002

Metabolic Eyeing Phase IIb Trial In Obesity After Positive IIa Study

Feb. 13, 2002

Biota Purchases U.S. Company With Antivirals Program For $8M

May 30, 2001

Biota Purchases U.S. Company With Antivirals Program For $8M

May 30, 2001

Rothschild Planning New Fund For Australian Biotech Firms

May 16, 2001

Rothschild Planning New Fund For Australian Biotech Firms

May 16, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...